Evidence map›Paper›PMID 29398058›Full record

Observational studyThe Journal of pediatrics2018

Neurocognitive Function in Children with Primary Hypertension after Initiation of Antihypertensive Therapy.

Marc B Lande, Donald L Batisky, Juan C Kupferman, Joshua Samuels, Stephen R Hooper, Bonita Falkner, Shari R Waldstein, Peter G Szilagyi, Hongyue Wang, Jennifer Staskiewicz and 1 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in The Journal of pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Antihypertensives in Children and Adolescents.Current hypertension reports · 2022
    Review
  6. The enigma of primary hypertension in childhood.Frontiers in cardiovascular medicine · 2022
    Review
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 1 country.

Marc B LandeDepartment of Pediatrics, University of Rochester, Rochester, NY. Electronic address: Marc_lande@urmc.rochester.edu.
Donald L BatiskyDepartment of Pediatrics, Emory University, Atlanta, GA.
Juan C KupfermanDepartment of Pediatrics, Maimonides Medical Center, Brooklyn, NY.
Joshua SamuelsDepartment of Pediatrics, McGovern Medical School at UTHealth, Houston, TX.
Stephen R HooperDepartments of Allied Health Sciences and Psychiatry, University of North Carolina, Chapel Hill, NC.
Bonita FalknerDepartment of Pediatrics, Thomas Jefferson University, Philadelphia, PA.
Shari R WaldsteinDepartment of Psychology, University of Maryland, Baltimore County, Baltimore, MD.
Peter G SzilagyiDepartment of Pediatrics, University of California at Los Angeles (UCLA), Los Angeles, CA.
Hongyue WangDepartment of Biostatistics, University of Rochester, Rochester, NY.
Jennifer StaskiewiczDepartment of Pediatrics, University of Rochester, Rochester, NY.
Heather R AdamsDepartment of Neurology, University of Rochester, Rochester, NY.
University of Rochester · USEmory University · USMaimonides Medical Center · USThe University of Texas Health Science Center at Houston · USThomas Jefferson University · USUniversity of California, Los Angeles · USUniversity of Maryland, Baltimore County · USUniversity of North Carolina at Chapel Hill · USUniversity of Rochester Medical Center · US

Funding

The University of Rochester's Clinical and Translational Science InstituteUL1TR002001 · NCATS · UNIVERSITY OF ROCHESTER · PI WILSON, KAREN M., ZAND, MARTIN S · 2016 to 2024
$34.6M
The University of Rochester's Clinical and Translational Science InstituteUL1TR000042 · NCATS · UNIVERSITY OF ROCHESTER · PI BENNETT, NANCY M, KIEBURTZ, KARL D. · 2012 to 2015
$14.4M
Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
White Matter Integrity and Cognitive Performance in Adolescents with Primary HypertensionR01HL098332 · NHLBI · UNIVERSITY OF ROCHESTER · PI LANDE, MARC B · 2010 to 2023
$5.7M
NCATS NIH HHS UL1 TR000042NCATS NIH HHS UL1 TR000371NCATS NIH HHS UL1 TR002001NHLBI NIH HHS R01 HL098332
6 · The paper itself

Abstract

objectiveTo determine the change in neurocognitive test performance in children with primary hypertension after initiation of antihypertensive therapy. STUDY

designSubjects with hypertension and normotensive control subjects had neurocognitive testing at baseline and again after 1 year, during which time the subjects with hypertension received antihypertensive therapy. Subjects completed tests of general intelligence, attention, memory, executive function, and processing speed, and parents completed rating scales of executive function.

resultsFifty-five subjects with hypertension and 66 normotensive control subjects underwent both baseline and 1-year assessments. Overall, the blood pressure (BP) of subjects with hypertension improved (24-hour systolic BP load: mean baseline vs 1 year, 58% vs 38%, P < .001). Primary multivariable analyses showed that the hypertension group improved in scores of subtests of the Rey Auditory Verbal Learning Test, Grooved Pegboard, and Delis-Kaplan Executive Function System Tower Test (P < .05). However, the control group also improved in the same measures with similar effects sizes. Secondary analyses by effectiveness of antihypertensive therapy showed that subjects with persistent ambulatory hypertension at 1 year (n = 17) did not improve in subtests of Rey Auditory Verbal Learning Test and had limited improvement in Grooved Pegboard.

conclusionsOverall, children with hypertension did not improve in neurocognitive test performance after 1 year of antihypertensive therapy, beyond that also seen in normotensive controls, suggesting improvements with age or practice effects because of repeated neurocognitive testing. However, the degree to which antihypertensive therapy improves BP may affect its impact upon neurocognitive function.

Indexed as

Neuropsychological TestsAdolescentAntihypertensive AgentsBlood PressureCase-Control StudiesChildExecutive FunctionFemaleHumansHypertensionMaleProspective StudiesAntihypertensive Agentsblood pressureneuropsychological testingobesitytreatment

Identifiers

PMID29398058
PMCPMC5869096
OpenAlexW2789829615

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.